Use of clobetasol in lacquer for plaque psoriasis treatment
AUTOR(ES)
Silva, Suze Aparecida da, Magalhães, Renata Ferreira, Torres, Rafael Augusto Tamasauskas, Oliveira, Raquel Diana de, Velho, Paulo Eduardo Neves Ferreira
FONTE
An. Bras. Dermatol.
DATA DE PUBLICAÇÃO
2016-02
RESUMO
Abstract Clobetasol benefits to control psoriasis lesions are well defined, but there were not studies about its action when used in lacquer vehicle to control skin lesions. A double-blind study was conducted with 40 patients that utilized clobetasol 0.05% in one hemibody and just the vehicle in the other hemibody. Twenty of them used petrolatum as vehicle and the others used lacquer. An assessment was conducted using the clinical index PASI and a quality of life questionnaire (Dermatological Life Quality Index). There was no statistical difference between groups. There was a trend of favorable response particularly in the hemibody treated with clobetasol.
Documentos Relacionados
- Psoriasis in moderate grave plaque - immunobiological treatment
- Moderate to severe plaque psoriasis - treatment with drugs of the classic scheme
- Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology
- Interstitial lung disease due to anti-TNF use in the treatment of psoriasis
- The Treatment of Psoriasis
